1,025 followers
Long-term response of metastatic hereditary leiomyomatosis and renal cell carcinoma syndrome associated renal cell carcinoma to bevacizumab plus erlotinib after temsirolimus and axitinib treatment failures https://t.co/ea18fN5uDT via @BioMedCentral #OpenAc